Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Assets (2016 - 2025)

Corcept Therapeutics' Return on Assets history spans 10 years, with the latest figure at 0.12% for Q4 2025.

  • For Q4 2025, Return on Assets fell 5.0% year-over-year to 0.12%; the TTM value through Dec 2025 reached 0.12%, down 5.0%, while the annual FY2025 figure was 0.12%, 7.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.12% at Corcept Therapeutics, down from 0.13% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.25% in Q1 2022 and bottomed at 0.12% in Q4 2025.
  • The 5-year median for Return on Assets is 0.17% (2021), against an average of 0.18%.
  • The largest annual shift saw Return on Assets rose 7bps in 2022 before it fell -9bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.22% in 2021, then fell by -19bps to 0.18% in 2022, then dropped by -4bps to 0.17% in 2023, then dropped by 0bps to 0.17% in 2024, then plummeted by -31bps to 0.12% in 2025.
  • Per Business Quant, the three most recent readings for CORT's Return on Assets are 0.12% (Q4 2025), 0.13% (Q3 2025), and 0.16% (Q2 2025).